Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins
- 31 January 1992
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 92 (1), 49-57
- https://doi.org/10.1016/0021-9150(92)90009-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cholesteryl ester transfer proteinThe Lancet, 1991
- Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterolAmerican Heart Journal, 1991
- Accelerated cholesteryl ester transfer in patients with insulin‐dependent diabetes mellitusEuropean Journal of Clinical Investigation, 1991
- Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transferAtherosclerosis, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.Journal of Clinical Investigation, 1987
- Studies on the mechanism of action of probucolThe American Journal of Cardiology, 1986
- Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemiaAtherosclerosis, 1985
- Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.Journal of Clinical Investigation, 1984
- Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.Journal of Clinical Investigation, 1983